Literature DB >> 24497809

Von Hippel-Lindau syndrome: demonstration of entire disease spectrum with (68)Ga-DOTANOC PET-CT.

Punit Sharma1, Varun Singh Dhull1, Chandrasekhar Bal1, Arun Malhotra1, Rakesh Kumar1.   

Abstract

Von Hippel-Lindau (VHL) syndrome is a rare neoplastic disorder characterized by central nervous system (CNS) and visceral tumors. We here present (68)Ga-labelled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-Nal3-Octreotide positron emission tomography computed tomography findings in a 52 year old female with VHL syndrome, demonstrating both CNS and visceral tumors.

Entities:  

Keywords:  68Ga-DOTANOC; Hemangioblastoma; NET; PET-CT; RCC; Von Hippel-Lindau syndrome

Mesh：

Substances：

Year:  2014        PMID： 24497809      PMCID： PMC3909852          DOI： 10.3348/kjr.2014.15.1.169

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN： 1229-6929            Impact factor:   3.500


  10 in total

1.  Von Hippel-Lindau disease.

Authors:  Stéphane Richard; Joyce Graff; Jan Lindau; François Resche
Journal:  Lancet       Date:  2004-04-10       Impact factor: 79.321

2.  Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours.

Authors:  Rakesh Kumar; Punit Sharma; Pramod Garg; Sellam Karunanithi; Niraj Naswa; Raju Sharma; Sanjay Thulkar; Sneh Lata; Arun Malhotra
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

3.  Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.

Authors:  J C Reubi; B Waser; J A Laissue; J O Gebbers
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

4.  68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.

Authors:  Valentina Ambrosini; Davide Campana; Vincenzo Allegri; Giuseppe Opocher; Stefano Fanti
Journal:  Clin Nucl Med       Date:  2011-01       Impact factor: 7.794

5.  Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study.

Authors:  Niraj Naswa; Punit Sharma; Aftab Hasan Nazar; Krishan Kant Agarwal; Rakesh Kumar; Ariachery C Ammini; Arun Malhotra; Chandrasekhar Bal
Journal:  Eur Radiol       Date:  2011-10-05       Impact factor: 5.315

Review 6.  von Hippel-Lindau disease: a clinical and scientific review.

Authors:  Eamonn R Maher; Hartmut Ph Neumann; Stéphane Richard
Journal:  Eur J Hum Genet       Date:  2011-03-09       Impact factor: 4.246

7.  Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

Authors:  Stefano Fanti; Valentina Ambrosini; Paola Tomassetti; Paolo Castellucci; Giancarlo Montini; Vincenzo Allegri; Gaia Grassetto; Domenico Rubello; Cristina Nanni; Roberto Franchi
Journal:  Biomed Pharmacother       Date:  2008-03-03       Impact factor: 6.529

8.  Somatostatin receptors in human renal cell carcinomas.

Authors:  J C Reubi; L Kvols
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

9.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

Review 10.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321
  10 in total
  4 in total

1.  Recurrent Pheochromocytomas in a Child with Familial von Hippel-Lindau Syndrome.

Authors:  Djordje Savic; Maja Milickovic; Sladjana Todorovic; Miroslav Vukadin; Aleksandar Vlahovic; Blagoje Grujic; Mila Stajevic
Journal:  Indian J Pediatr       Date:  2016-04-29       Impact factor: 1.967

2.  Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.

Authors:  Saman Sizdahkhani; Michael J Feldman; Martin G Piazza; Alexander Ksendzovsky; Nancy A Edwards; Abhik Ray-Chaudhury; Dragan Maric; Marsha J Merrill; Karel Pacak; Zhengping Zhuang; Prashant Chittiboina
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

3.  A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy, Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography.

Authors:  Pelin Arıcan; Berna Okudan Tekin; Seniha Naldöken; Rıza Şefizade; Dilek Berker
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

4.  From arterial hypertension complications to von Hippel-Lindau syndrome diagnosis.

Authors:  Sylwia Kozaczuk; Iwona Ben-Skowronek
Journal:  Ital J Pediatr       Date:  2015-08-13       Impact factor: 2.638
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.